ArticleCurrent microbiology2026
Identification of Novel Polysaccharide from Myxococcus xanthus and its Function in Developmental Sporulation.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Myxococcus xanthus is a Gram-negative bacterium with a complex life cycle that includes vegetative swarming and fruiting-body formation. Previous studies have shown that the exopolysaccharides (EPS) produced by M. xanthus was essential for the developmental process, but the information concerning EPS structure in M. xanthus was lacking. In this study, a novel soluble polysaccharide EPS15M was purified from the extracellular supernatant of M. xanthus DK1622, which was mainly composed of mannose, glucose, glucosamine, and rhamnose. Methylation analysis suggested the prevalence of terminal and 2-linked glycosyl residues, consistent with a branched structure. NMR and liquid chromatography-mass spectrometry analyses confirmed that EPS15M is an α-D-(1,2)-linked mannan backbone with α-D-(1,6)-linked mannose/glucose branches, a structure that differs from any extracellular polysaccharide reported to date from myxobacteria. Besides, EPS15M modestly improves the developmental sporulation of the csgA mutant (approximately 17% of the wild‑type level) at a concentration of 0.1 mg/mL. Collectively, our findings present the first high-resolution structure of a soluble exopolysaccharide from myxobacteria and demonstrate its partial functional compensation of csgA mutant, suggesting that EPS15M may be involved in C‑signal‑mediated developmental sporulation. These results open new avenues for understanding the regulatory role of polysaccharides in the myxobacterial life cycle.
Indexed as
Identifiers
42547578What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.